$25.730
+0.625 (+2.43%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
KMTS 相似图表分析预测
Alphio's KMTS stock price prediction model matches the current Kestra Medical Technologies Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $25.43 (+1.16%). The 1-week path is $25.91 (+3.06%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Kestra Medical Technologies Ltd 股票吗？
Kestra Medical Technologies (KMTS) is currently not a strong buy due to its low RSI of 23.147, indicating oversold conditions, and a recent 5-day price drop of 5.00%. However, the company has shown significant revenue growth, with Q2 2026 revenue at $22,565,000, a 63% year-over-year increase in prescription volume, and a positive analyst outlook with a price target of $30 from JPMorgan. The main risk is its negative net income, which was -$38,835,000 in Q4 2026, indicating ongoing financial challenges.
KMTS 股价于 Wednesday 收于 $25.73，此前上涨 +2.43%
Kestra Medical Technologies Ltd (KMTS) last closed at $25.14, losing -2.29%. These facts feed the 1-day and 1-week KMTS price prediction above.
预测驱动因素
Kestra Medical Technologies Ltd（KMTS）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
相似图表形态
近期走势与 KMTS 最接近的股票，按相似度排序。
KMTS 季节性分析
Historically the probability of a positive September return for KMTS is 62.50%. October offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。